Data as of Apr 17
| +0.21 / +6.80%|
The 1 analysts offering 12-month price forecasts for CollabRx Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +203.03% increase from the last price of 3.30.
The current consensus among 1 polled investment analysts is to Buy stock in CollabRx Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.